Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-29 @ 6:58 AM
Study NCT ID:
NCT05886868
Status:
UNKNOWN
Last Update Posted:
2023-11-29
First Post:
2023-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors
Sponsor:
Shanghai Best-Link Bioscience, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-24
First Submit QC Date:
None
Study First Post Date:
2023-06-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-24
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL